Protein therapeutics worth $77bn by 2011, says RNCOS
The global protein therapeutics market will be worth $77bn by 2011 with biogenerics playing an increasingly important role, according to a new survey by industry analysts RNCOS.
Archives for August 24, 2009
Sigma-Aldrich develops knockout rats
Sigma-Aldrich is using a novel methodology to create rats with targeted gene deletion in as little as four months, which it believes could eliminate years of research and improve drug development.
GSK reports theft of 25,600 Advair inhalers
UK drug major GSK says that two lots of its respiratory drug Advair Diskus have been stolen from a distribution facility in Richmond, Virginia in the US.
CRL teams up with Quotient for new European lab
US analysis group CRL will set up a new laboratory at Quotient Bioresearch’s facility in Cambridge in the UK, in a collaboration designed to expand the US company’s business on the global stage and extend Quotient's offering.
Encorium plans liquidation if subsidiary sold
Encorium plans to liquidate if it can negotiate the sale of its Finland-based business, which could happen in the fourth quarter.